Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma (2019) Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J Conference contribution Multicentric Sentinel Healthcare Research Project of Skin Cancer Centers in Nuremberg, Erlangen, Regensburg and Wuerzburg (2019) Enzelsberger K, Debus D, Schultz E, Haferkamp S, Hegemann MV, Stolze I, Erdmann M, Schellerer V Conference contribution ECP as prognostic Marker for Melanoma (2019) Moreira A, Krueckel A, Schuler G, Utikal J, Heinzerling L Conference contribution Blood eosinophilia is an on-treatment biomarker in patients undergoing vaccination with dendritic cells that correlates with long-term patient outcome (2019) Moreira A, Vass V, Erdmann M, Sponagl F, Schuler G, Schuler-Thurner B Conference contribution Do Patients with Lower Limb Melanoma have an increased Risk of a "false negative" Sentinel Node Biopsy? (2019) Braun L, Schellerer V, Schuler G, Goeol J, Erdmann M Conference contribution Successful Treatment of a primary cutaneous aggressive epidermotropic CD8+T-cell Lymphoma with Nivolumab (2019) Toussaint F, Erdmann M, Grosch E, Schuler G, Schliep S, Heinzerling L Conference contribution Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses (2019) Moreira A, Gross S, Uslu U, Dörrie J, Kummer M, Schliep S, Sponagl F, et al. Conference contribution Systemic sclerosis - the dermatological perspective (2019) Sticherling M Journal article Psychiatric disorders are common comorbidities in patients with chronic spontaneous or inducible urticaria in Germany (2019) Weller K, Maurer M, Bauer A, Wedi B, Wagner N, Schliemann S, Baeumer D, et al. Conference contribution